• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues.

作者信息

Choudhury Ananya, Hoskin Peter J

机构信息

Manchester Cancer Research Centre, Division of Cancer Science, School of Medical Sciences, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Manchester Cancer Research Centre, Division of Cancer Science, School of Medical Sciences, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

出版信息

Eur Urol. 2019 Jul;76(1):69-70. doi: 10.1016/j.eururo.2019.01.040. Epub 2019 Feb 4.

DOI:10.1016/j.eururo.2019.01.040
PMID:30732925
Abstract
摘要

相似文献

1
Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues.肌肉浸润性膀胱癌的预测生物标志物：寻找圣杯的征程仍在继续。
Eur Urol. 2019 Jul;76(1):69-70. doi: 10.1016/j.eururo.2019.01.040. Epub 2019 Feb 4.
2
Reply from Authors re: Ananya Choudhury, Peter J. Hoskin. Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues. Eur Urol 2019;76:69-70: Towards Biomarker-Informed Management of Muscle-Invasive Bladder Cancer.作者回复：关于阿南雅·乔杜里、彼得·J·霍斯金。肌层浸润性膀胱癌的预测生物标志物：寻找圣杯仍在继续。《欧洲泌尿外科杂志》2019年；76卷：69 - 70页：迈向基于生物标志物的肌层浸润性膀胱癌管理
Eur Urol. 2019 Jul;76(1):71-72. doi: 10.1016/j.eururo.2019.03.009. Epub 2019 Mar 23.
3
Predicting Response to Intravesical Therapy in Non-muscle-invasive Bladder Cancer.预测非肌肉浸润性膀胱癌对膀胱内治疗的反应。
Eur Urol Focus. 2018 Jul;4(4):494-502. doi: 10.1016/j.euf.2018.07.032. Epub 2018 Aug 8.
4
Biomarkers for bladder cancer: The search continues!膀胱癌的生物标志物：探索仍在继续！
Investig Clin Urol. 2016 Mar;57(2):73-4. doi: 10.4111/icu.2016.57.2.73. Epub 2016 Feb 29.
5
MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.肿瘤样本和尿液细胞外囊泡中的 microRNAs 作为肌肉浸润性膀胱癌的一种潜在诊断工具。
J Cancer Res Clin Oncol. 2019 Nov;145(11):2725-2736. doi: 10.1007/s00432-019-03035-6. Epub 2019 Sep 24.
6
Urinary biomarkers in bladder cancer: where do we stand?膀胱癌的尿生物标志物：我们处于什么位置？
Curr Opin Urol. 2019 May;29(3):203-209. doi: 10.1097/MOU.0000000000000605.
7
Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles.膀胱癌的诊断和随访：细胞外囊泡的现状和可能作用。
Int J Mol Sci. 2019 Feb 14;20(4):821. doi: 10.3390/ijms20040821.
8
Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer.治疗前淋巴细胞减少是肌层浸润性和晚期膀胱癌的不良预后生物标志物。
Ann Oncol. 2016 Feb;27(2):294-9. doi: 10.1093/annonc/mdv546. Epub 2015 Nov 16.
9
Recent Developments in the Search for Urinary Biomarkers in Bladder Cancer.膀胱癌尿液生物标志物研究的最新进展
Curr Urol Rep. 2017 Nov 13;18(12):100. doi: 10.1007/s11934-017-0748-x.
10
The role of biomarkers in bladder preservation management of muscle-invasive bladder cancer.生物标志物在肌层浸润性膀胱癌膀胱保留治疗管理中的作用。
World J Urol. 2019 Sep;37(9):1767-1772. doi: 10.1007/s00345-018-2480-7. Epub 2018 Sep 14.

引用本文的文献

1
UCHL5 Promotes Proliferation and Migration of Bladder Cancer Cells by Activating c-Myc via AKT/mTOR Signaling.UCHL5通过AKT/mTOR信号通路激活c-Myc促进膀胱癌细胞的增殖和迁移。
Cancers (Basel). 2022 Nov 10;14(22):5538. doi: 10.3390/cancers14225538.
2
BRCC3 Promotes Tumorigenesis of Bladder Cancer by Activating the NF-κB Signaling Pathway Through Targeting TRAF2.BRCC3通过靶向TRAF2激活NF-κB信号通路促进膀胱癌的肿瘤发生。
Front Cell Dev Biol. 2021 Sep 16;9:720349. doi: 10.3389/fcell.2021.720349. eCollection 2021.